INTRODUCTION
Articular cartilage is the load-bearing tissue that lines the ends of long bones in diarthrodial joints, serving to resist compression and provide a nearly frictionless surface during joint loading and movement (Guilak, 2011; Mansour, 2009 ). The extracellular matrix of cartilage is comprised primarily of type II collagen and proteoglycans, which are synthesized by the main residing cell type, chondrocytes (Fox et al., 2009; Lin et al., 2006) . However, because it is aneural and avascular, cartilage shows little or no capacity for intrinsic repair (Fox et al., 2009) . Traumatic injury and a chronic inflammatory state lead to irreversible degeneration of the tissue, driving diseases such as osteoarthritis (OA) (Berenbaum et al., 2016; Lieberthal et al., 2015) . Current treatments only target disease symptoms, creating a great demand for tissue-engineered cartilage as a system for disease modeling, drug testing, and tissue replacement.
Human induced pluripotent stem cells (hiPSCs) offer a promising source for cartilage tissue engineering and in vitro disease modeling (Musunuru, 2013) as they have virtually unlimited expansion capacity, can be genetically modified, and avoid many of the ethical considerations associated with embryonic stem cells (Takahashi et al., 2007; Yumlu et al., 2017) . Despite reports of several chondrogenic differentiation protocols for pluripotent stem cells (Craft et al., 2015; Lee et al., 2015; Lian et al., 2010; Nejadnik et al., 2015; Suchorska et al., 2017; Yamashita et al., 2015) , incomplete differentiation and cell heterogeneity remain major obstacles for iPSC chondrogenesis (Cahan and Daley, 2013; Yoshida and Yamanaka, 2010) . This challenge has been addressed in other stem and progenitor cell types by prospectively isolating cells that exhibit chondrogenic lineage commitment using surface marker expression. For example, previous studies have identified chondroprogenitors within adult articular cartilage that can be isolated using fibronectin adhesion assays since progenitors express integrins a5 and b1 (Vinod et al., 2018; Williams et al., 4 2010) . Additionally, mesenchymal progenitor cells, which express CD105, CD166, and CD146, have been reported to have a high chondrogenic potential (Alsalameh et al., 2004; Su et al., 2015; Vinod et al., 2018) . Adult multipotent cells, such as bone marrow mesenchymal stem cells (MSCs) or adipose stem cells (ASCs), exhibit chondrogenic potential and have been used extensively for cartilage tissue engineering. They are often characterized by a range of cell surface marker expression, including CD105, CD73, CD90, CD271, CD146, Stro-1, and SSEA-4 (Lv et al., 2014) .
In an effort to identify a more developmentally-relevant progenitor population, self-renewing human skeletal stem cells characterized by CD164 + , CD73 -, and CD146showed chondrogenic differentiation when implanted in a mouse renal capsule (Chan et al., 2018) . In another study, limb bud cells expressing CD73 and BMPR1b while having low to no expression of CD166, CD146, and CD44 were proposed to be the earliest cartilage committed cells (prechondrocytes) in human embryonic development (Wu et al., 2013) . However, surface markers characteristic of hiPSCderived chondroprogenitors or chondrocytes remain to be identified.
Previously, our lab used green fluorescent protein (GFP) reporter systems to track the expression of collagen type II alpha 1 chain (COL2A1) in mouse (Diekman et al., 2012) and human (Adkar et al., 2018) iPSCs, allowing for the prospective isolation and purification of COL2A1-GFP+ chondrogenic cells during the differentiation process. Despite the fact that this approach significantly enhanced iPSC chondrogenesis (Adkar et al., 2018) , genome editing is required to create a reporter line, hindering potential clinical translation. In this regard, the identification of cell surface markers that are directly representative of this COL2A1-positive population could greatly enhance the prospective isolation and purification of chondroprogenitors, without requiring genetic modifications to the cell line.
In this study, we used a COL2A1-GFP knock-in reporter hiPSC line as a tool to identify cell surface markers that are highly co-expressed with COL2A1 to test the hypothesis that this subpopulation of chondroprogenitor cells will show increased purity and chondrogenic capacity.
Single-cell RNA sequencing (scRNA-seq) was then used to investigate the gene expression profile of this population and to identify subsets within it. Matrix production, cell morphology, and gene expression were measured to evaluate chondrogenic ability of unsorted and sorted chondroprogenitor cells. This chondroprogenitor population appears to represent an intermediate step in the developmental pathway of hiPSC differentiation into chondrocytes. The identification of a purified population of chondroprogenitor cells will enhance the efficiency of hiPSCchondrogenic differentiation for use in tissue engineering, in vitro disease modeling, and drug testing.
RESULTS

COL2A1-positive chondroprogenitor cells express PDGFRb, CD146, and CD166
COL2A1-GFP reporter hiPSCs were differentiated into chondroprogenitor cells along the mesodermal lineage as previously described (Adkar et al., 2018) . After differentiation, the cells were labeled for surface markers commonly associated with MSCs and/or chondroprogenitors in the developing limb bud (Chan et al., 2018; Lv et al., 2014; Wu et al., 2013) . Flow cytometric analysis showed that, on average, 4.27% of the chondroprogenitor population expressed COL2A1 based on GFP expression ( Figure S1A ). Of the total population, less than 1% also expressed CD271, CD105, CD73, and BMPR1b. The chondroprogenitor cells had the highest expression of CD271 of the four markers, but it was not co-expressed with COL2A1 ( Figure S1C) . Interestingly, 6 PDGFRb, CD146, and CD166 were co-expressed with COL2A1 at the highest frequencies as 2.32%, 2.17%, and 1.32% of the total population, respectively ( Figure S1B) . Therefore, the presence of these three surface markers, and the absence of the hematopoietic marker CD45, were used to sort for chondroprogenitor cells (Figure 1A) .
Chondroprogenitor cells are triple positive for PDGFRb, CD146, and CD166
The BJFF hiPSC line (wildtype without genome editing) was differentiated into chondroprogenitor cells accordingly. Cells either directly underwent chondrogenic pellet culture, were expanded, were saved for scRNA-seq, or were labeled for the surface markers of interest ( Figure 1A) .
Fluorescent activated cell sorting (FACS) was used to sort live chondroprogenitor cells negative for CD45 and positively expressing PDGFRb and CD146, followed by expression of CD166 ( Figure 1B) . Cells not expressing any of these surface markers were also analyzed as a negative control. Approximately 16.5% of the total chondroprogenitor cell population was triple positive for PDGFRb, CD146, and CD166, which was significantly higher than the percentage of the cells (7.2% of total) that were triple-negative for these markers (Figure 1C) . Sorted cells were collected and either pelleted for chondrogenesis, expanded or saved for scRNA-seq, as described in Figure   1A .
scRNA-seq reveals that unsorted chondroprogenitor cells contained diverse cell populations
We next used scRNA-seq to explore the cell diversity and genetic profiles of unsorted chondroprogenitor cells. At least 9 distinct cell populations (cell clusters) were observed in unsorted chondroprogenitor cells (Figure 2A) . Among these populations, 5 of them were enriched for a variety of neural cell markers such as SOX2, OTX1, NES, and PAX6 (Figure 2B ), likely 7 representing populations of the neurogenic lineage. Furthermore, we found that 3 cell populations exhibited high expression levels of several mesenchyme markers including PRRX1, COL1A1, COL5A1, and COL6A1, while only a small cell population (2.3% of total) expressed chondrogenic markers such as SOX9, COL2A1, IGFBP5, and NKX3-2 (Figure 2C) . To understand biological function of each population, we then perform Gene Ontology (GO) enrichment analysis of the gene sets representing each cell cluster (Figure 2D and S2A) . We observed that SOX2/TTR/NES+ cells were enriched for genes of forebrain development, while cells expressing SOX9 and COL2A1 demonstrated gene sets enriched for protein translation and skeletal system development.
Interestingly, SOX2/SOX3/TOP2A+ and PRRX1/HIST1H4C/CDK1+ cell populations, found in neurogenic and mesenchymal lineages, respectively, were both enriched for cell cycle genes ( Figure 2D ). We subsequently assigned each individual cell a cell cycle phase (i.e., G1, S, or G2M) based on the expression of cell cycle genes. We found that 75% of SOX9/COL2A1 were in quiescent, non-proliferating G1 state.
scRNA-seq reveals that sorting enriched SOX9/COL2A1+ cells scRNA-seq of sorted chondroprogenitor cells indicated that there were at least 6 cell populations consisting of PDGFRb + /CD146 + /CD166 + cells ( Figure 3A) . Surprisingly, there was still a small percentage of cells (4% of total sorted cells) expressing SOX2 and NES, despite the stringent sorting regime (Figures 3B and 3C) . We also observed that SOX2/NES+ cells exhibited high expression of CD47, an integrin-associated protein (Brown and Frazier, 2001) (Figure S2B) .
Nevertheless, sorting still significantly enriched cells positive for SOX9 and COL2A1 by > 11-fold (27% of total sorted cells). Additionally, we also observed that gene expression levels of the sorting makers were enriched in the sorted cells expressing SOX9 and COL2A1 ( Figure 3D) . Similarly, there was enrichment of some previously reported pro-chondrogenic markers (Alsalameh et al., 2004; Vinod et al., 2018; Williams et al., 2010; Wu et al., 2013) in the sorted chondroprogenitor population; specifically ITGA5 and ENG (CD105) (Figure S3) . Skeletal system development, as expected, emerged as a significant GO term in SOX9/COL2A1+ cells, while HMGB2/TOP2A+ and LGALS1/PTTG1+ cells were enriched in gene sets of cell division (Figure 3E and S2C) .
Similar to unsorted cells, the majority of SOX9/COL2A1+ cells (> 80%) were in quiescent G1 status of cell cycle (Figure 3F ).
Canonical correlation analysis (CCA) analysis demonstrates high enrichment of proliferative and mesenchymal genes in sorted chondroprogenitor cells
Five major conserved populations were identified after CCA alignment of the sorted and unsorted chondroprogenitor cells (Figure 4A ). Among these populations, HIST1H4C+ cells accounted for the major conserved population, while the IGFBP5/COL2A1+ cluster was the smallest. We next performed differentially expression gene (DEG) analysis to explore how sorting enriches or depletes the levels of gene expression within each individual population ( Figure 4B ). Within the IGFBP5/COL2A1+ population, sorted cells exhibited significantly up-regulated expression of several mesenchymal genes including TPM1, TAGLN and TMSB10 (indicated by brown circle), which have been suggested to be essential in chondrogenesis (Molnar et al., 2007; Zhang et al., 2018) . Furthermore, within IGFBP5/COL2A1+ population, sorted cells demonstrated significantly down-regulated expression of IGFBP5 (indicated by blue circle), an important transcription factor inducing chondroprogenitor cells into chondrogenic lineage (Clemmons, 1993) .
Sorting improved matrix production and homogeneity in cartilaginous pellets
Sorted and unsorted cells from both the reporter and wildtype lines underwent chondrogenesis in pellet culture for 28 days. Pellets stained with safranin-O for sulfated glycosaminoglycans (sGAGs) showed that sorting increased matrix production as well as homogeneity of cell morphology (Figure 5A) . Additionally, the layer of non-cartilaginous-like cells surrounding unsorted cell pellets was eliminated in the pellets derived from sorted cells. Biochemical analysis demonstrated that sorting significantly increased the ratio of sGAGs to DNA in pellets by over 20fold (unsorted: 1.4 ng/ng vs. sorted: 31.8 ng/ng, Figure 6A ). Similarly, there was an increase in production and homogeneity observed in sorted pellets labeled for COL2A1 ( Figure 5B ). In addition, IHC labeling for COL1A1 showed a slight decrease while that labeling for COL10A1 showed an increase in the respective matrix proteins with sorting ( Figure 5C and 5D) .
Additionally, pellets formed with sorted cells had more concentrated staining of COL6A1 around the cells as shown with IHC compared to the more diffused pattern observed with unsorted cells (Figure S5) .
DISCUSSION
Using a COL2A1-GFP reporter line, we have identified a novel combination of surface markers (i.e., PDGFRb + /CD146 + /CD166 + /CD45 -) depicting a unique progenitor population with robust chondrogenic potential in hiPSC chondrogenesis. This finding was further confirmed by significantly increased cartilaginous matrix production of the prospectively isolated cells with these selected markers from a wildtype, non-edited hiPSC line. The results of scRNA-seq of sorted cells revealed that cells positive for PDGFRb, CD146, and CD166 exhibited enhanced cell homogeneity with decreased neurogenic subpopulations. These findings support the hypothesis that sorting of hiPSC-derived chondroprogenitor cells using surface markers can be used to purify progenitor cells with enhanced chondrogenic potential, without the need for genetic modification to improve hiPSC chondrogenesis (Adkar et al., 2018; Diekman et al., 2012) .
We previously reported that chondroprogenitor cells at the end of mesodermal lineage differentiation had high expression of CD146 and CD166 (Adkar et al., 2018) . In the present study, we observed that these markers were also highly co-expressed with COL2A1. CD146 and CD166, along with CD105, have also been shown to be expressed in chondroprogenitors in articular cartilage (Alsalameh et al., 2004; Su et al., 2015; Vinod et al., 2018) . While our chondroprogenitor cells did not co-express CD105 (ENG) with COL2A1, sorting did enrich CD105 expression.
Interestingly, it has been shown that CD105 itself may not indicate chondrogenic potential (Cleary et al., 2016) . In addition, scRNA-seq showed that sorted cells exhibited increased expression of ITGB1 (CD29) and ITGA5 (CD49e), which have been deemed necessary for chondrogenic differentiation in progenitor cells and MSCs (Cicione et al., 2010; Vinod et al., 2018; Williams et al., 2010) . Nevertheless, our chondroprogenitor cells had somewhat different expression profiles than skeletal progenitor cells identified previously in vivo (Chan et al., 2018; Wu et al., 2013) .
Moderate expression of CD164, a surface marker of the skeletal stem cell (Chan et al., 2018) , was conserved between the unsorted and sorted chondroprogenitor cells while many other markers described were absent from both populations including prechondrocyte markers BMPR1b and CD73 (NT5E) (Wu et al., 2013) . Therefore, the chondroprogenitor population described in this study is a distinct, unique subpopulation of iPSCs that possesses robust chondrogenic potential.
Several factors may contribute to the differences in cell surface markers that have identified as markers of chondrogenesis in these different cell types. First, in our study we used a differentiation protocol which follows the paraxial mesodermal lineage of cartilage (Adkar et al., 2018; Loh et al., 2016) . Different types of cartilage follow various developmental pathways (e.g., paraxial mesoderm vs. lateral plate mesoderm) and therefore the other studies could be investigating these lineages, thus the cells would have different surface marker expression during differentiation (Bronner and Ledouarin, 2012; Decker et al., 2014; Loh et al., 2016) . Another explanation may be the time point along the developmental pathway in which the cells are being investigated. Our surface marker profiles are based on the expression of COL2A1. While COL2A1 is one of the most prominent matrix proteins in articular cartilage (Sophia Fox et al., 2009 ) and can indicate chondrogenic potential and determination of a chondrogenic fate (Grant et al., 2000) , COL2A1 is a relatively late marker of chondrogenesis (Kosher and Solursh, 1989) . Therefore, differences between the cell surface markers identified in our study as compared to other previous work may reflect differences in the prescribed differentiation pathway or the specific subpopulation identified.
In addition to the fact that COL2A1 expression is a later chondrogenic marker, COL2A1 expression was found throughout the entire unsorted populations including neurogenic cells, indicating that COL2A1+ cells were heterogenous. This finding is consistent with studies showing that COL2A1 expression may be a broader indicator for the initial lineage specification of a variety of tissues rather than a sole marker for chondrogenesis during embryonic development (Kosher and Solursh, 1989; Kulyk et al., 1991; Nah et al., 1988) . Indeed, it has been reported that COL2A1 is expressed in the floor plate of the central nervous system (Yan et al., 1995) , which provides a plausible explanation for our observation of COL2A1 expression in neurogenic cells. Following sorting, the size of the chondrogenic SOX9/COL2A1 population was increased and, while the neural SOX2 populations were reduced, a SOX2/TTR population still remained. In fact, this population had high expression of CD47, an integrin-associated and modulating protein (Brown and Frazier, 2001 ) that could be used as an additional marker for sorting in future experiments to improve homogeneity. The expression of nestin and several mesenchyme markers appeared to be permissive in sorted cells, suggesting that PDGFRb/CD146/CD166 triple-positive cells may have 13 a similar signature as neural crest cells (Cile Coste et al., 2017; Isern et al., 2014) and might come primarily from mesenchyme populations in unsorted cells. Nonetheless, despite the presence of 6 unique cell clusters, including the SOX2/TTR population, sorted chondroprogenitor cells showed robust chondrogenic capacity.
The sorted chondroprogenitors, which all express PDGFRb, CD146, and CD166, were found to be localized in the mesenchyme clusters of unsorted cells. Alignment of the unsorted and sorted populations by CCA allowed us to compare similarities and differences between the two groups. After alignment, the largest cell cluster expressed histone H4 (HIST1H4C). Histones are primarily synthesized during the S-phase of the cell cycle to package the replicated DNA (Osley, 1991) , thus indicating the large portion of cells in both sorted and unsorted populations are proliferative. Since scRNA-seq only captures a snap shot in time of the cells' RNA profiles, it is difficult to tell which proliferating cells may give rise to the desired populations when they transition to the G1 phase. Additionally, it has been shown that transcriptional activity is significantly altered between the G1 and S/G2/M phases (Zopf et al., 2013) . Therefore, it is likely that if the cell cycles were synchronized, there would be more homogenous transcriptional profiles.
Furthermore, there was a decrease in insulin-like growth factor binding protein-5 (IGFBP5) expression in sorted cells among the IGFBP5/CO2A1 population compared to unsorted. IGFBP5 plays a role in insulin-like growth factor-1 (IGF-1)-dependent chondrocyte proliferation (Kiepe et al., 2001) and protects cartilage during OA-induced degeneration (Clemmons et al., 2002) . This may imply that sorted cells may be precursors not fully committed into chondrogenic linage in comparison with unsorted cells. This could be further supported by the observation that sorted cells had increased expression in neural crest and proliferation markers (i.e., SOX4 and TUBA1A, respectively) (Sviderskaya et al., 2009) . Indeed, for all populations identified in the sorted cells, we found that they exhibited elevated expression in proliferative and mesenchymal genes, further suggesting that sorted cells were primarily derived from mesenchyme populations in unsorted cells. Nonetheless, subpopulations in sorted cells still expressed unique gene signatures as shown by the clustering. This finding implies that chondrocytes may differentiate from mesenchyme cells with a variety of transcriptomic profiles if given the correct signaling cues with appropriate timing.
Cartilaginous pellets derived from sorted chondroprogenitor cells showed a significant increase in chondrogenic matrix production and gene expression along with the elimination of a surrounding layer of non-chondrocyte-like cells. Surprisingly, there was also a relatively small increase in IHC labeling of COL10A1, a matrix protein often associated with hypertrophic chondrocytes (Kronenberg, 2003; Pacifici et al., 1990) . Interestingly, COL6A1 was observed to be more localized around the cells in pellets derived from sorted cells. In developing neonatal cartilage, COL6A1 is found throughout the matrix, but with maturity it is only found in the pericellular matrix surrounding the chondrocytes Morrison et al., 1996; Sherwin et al., 1999) . The increased expression in COL10A1 at both mRNA and protein levels alongside the co-localization of COL6A1 around chondrocytes suggests that the chondrocytes derived from the sorted cells were at more mature stages as compared to the chondrocytes derived from unsorted cells after 28 days of chondrogenic culture.
As cell sorting can significantly reduce the number of functional cells (Shields et al., 2015) , we also examined the effects of cell expansion on differentiation potential of the sorted cells prior to chondrogenesis. Cells in the first passage following sorting exhibit high chondrogenic potential and s-GAG staining in pellet culture. However, in subsequent passages, cells showed signs of dedifferentiation and loss of chondrogenic capacity, similar to that observed in primary chondrocytes (Darling and Athanasiou, 2005) as well as similarly sorted mouse iPSCs (Diekman et al., 2012) . We used expansion media similar to that of MSC expansion media due to similarities of the cells. In the future, various expansion medias could be tested including altering the concentration of bFGF as the growth factor has been shown to maintain multipotency and chondrogenic capacity (Coutu and Galipeau, 2011) .
In conclusion, we have identified a unique chondroprogenitor population from hiPSCs which expresses PDGFRb, CD146, and CD166 and has strong chondrogenic potential. While the population does share some characteristics with previously defined chondroprogenitors and traditionally defined MSCs, it has a distinct profile. The methods and findings in this study will contribute to future cartilage tissue engineering and disease modeling studies to improve understanding and treatment of diseases such as osteoarthritis.
EXPERIMENTAL PROCEDURES
Experimental methods are briefly summarized. A detailed description is provided in supplemental information.
hiPSC lines and culture.
Two hiPSC lines were used in the current study: RVR COL2A1-GFP knock-in line (RVR) and BJFF.6 line (BJFF). Both lines were maintained on vitronectin coated plates (VTN-N; Fisher Scientific, Hampton, NH) with daily medium changes. Cells were passaged at approximately 90% confluency and induced into mesodermal differentiation at 40% confluency.
Mesodermal differentiation.
hiPSCs were induced into mesodermal differentiation in monolayer according to the previously published protocol (Adkar et al., 2018) . In brief, cells were fed daily with various cocktails of growth factors and small molecules driving lineage differentiation (anterior primitive streak, paraxial mesoderm, early somite, sclerotome, and chondroprogenitor) in differentiation medium.
Upon differentiation into the chondroprogenitor stage, cells were dissociated and were used for cell sorting and chondrogenic differentiation as appropriate.
Fluorescent activated cell sorting (FACS).
Chondroprogenitor cells were resuspended in FACS Buffer, and stained with various antibodies that are conventionally considered as markers for mesenchymal progenitor cells ( Supplemental   Table S1 ). Cells were then sorted by Aria-II FACS machine.
10X Chromium Platform scRNA-seq.
Cells were thawed at 37ºC and resuspended in PBS + 0.01% BSA at concentration of 2,000 cells/µl. Cell suspension were submitted to the Genome Technology Access Center (GTAC sequencing core) at Washington University in St. Louis for library preparation and sequencing. In brief, 10,000 cells per sample were loaded on a Chromium Controller (10x Genomics) for single capture.
Detailed methods for quality control and processing for scRNA-sea data are described in Supplemental Information.
Expansion of chondroprogenitor cells.
Sorted and unsorted chondroprogenitor cells were plated on non-coated flasks and cultured in MEM alpha media (Gibco) with 1% P/S, 50 μg/ml ascorbate, and 10 ng/ml FGF. Cells were fed every three days until 80-90% confluency prior to further expansion or chondrogenesis.
chondroprogenitor cells were passaged up to four times.
Chondrogenic differentiation.
Sorted, unsorted, and expanded chondroprogenitor cells were re-suspended at 2.5 x 10 5 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-b3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37ºC for 28 days. Medium was changed every 3-4 days.
Histology and Immunohistochemistry.
After chondrogenic differentiation, pellets were fixed and sectioned at 8 µm. Slides were either stained with Safranin-O and hematoxylin for glycosaminoglycans evaluation or labeled against various collagen antibodies including COL1A1, COL2A1, COL6A1, and COL10A1.
Biochemical analysis.
Chondrogenic pellets digested. The PicoGreen (Invitrogen, Carlsbad, CA) and dimethymethlyene blue, with chondroitin-4-sulfate as a standard, assays were used according to the protocols to quantify DNA and sGAG respectively.
Gene expression.
Day 28 pellets were homogenized. Gene expression was analyzed using the DDCT method relative to undifferentiated hiPSCs with the reference gene TATA-box-binding protein (TBP) (Livak and Schmittgen, 2001) . Sequences of primers can be found in the Supplemental Table S2 . 
